B-Cell-Activating Factor Affects the Occurrence of Thyroid Autoimmunity in Chronic Hepatitis C Patients Treated with Interferon Alpha
Chronic hepatitis C (CHC) patients frequently suffer from thyroid disorders during interferon therapy. However, the mechanism remains unclear. In this study, we investigated the association between serum B-cell-activating factor belonging to the TNF family (BAFF) levels and the presence of antithyro...
Saved in:
| Main Authors: | Yusuke Kajiyama, Kentaro Kikuchi, Atsuko Takai, Naomi Hosoya, Hiromi Hoshino, Kunihiko Hino, Hiroshi Miyakawa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Clinical and Developmental Immunology |
| Online Access: | http://dx.doi.org/10.1155/2012/247973 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chronic hepatitis b with type I diabetes mellitus and autoimmune thyroiditis development during interferon alpha therapy
by: Sukran Kose, et al.
Published: (2011-07-01) -
Exogenous interferon-alpha and interferon-gamma increase lethality of murine inhalational anthrax.
by: Jeffrey A Gold, et al.
Published: (2007-08-01) -
The Spectrum of Autoimmune Thyroid Disease in the Short to Medium Term Following Interferon-α Therapy for Chronic Hepatitis C
by: Huy A. Tran, et al.
Published: (2009-01-01) -
Occurrence of autoimmune chronic hepatitis in siblings
by: Nožić Darko, et al.
Published: (2005-01-01) -
Pegylated Interferon Alpha for Chronic Hepatitis B Virus Infection
by: Joana Vasconcelos, et al.
Published: (2022-01-01)